The aetiology of childhood leukaemia remains generally unknown, although exposure to moderate and high levels of ionizing radiation, such as those experienced during the atomic bombings of Japan or from radiotherapy, is an established cause. Risk models based primarily on studies of the Japanese atomic bomb survivors imply that low-level exposure to ionizing radiation, including ubiquitous natural background radiation, also raises the risk of childhood leukaemia. Using two sets of recently published leukaemia risk models and estimates of natural background radiation red-bone-marrow doses received by children, about 20% of the cases of childhood leukaemia in Great Britain are predicted to be attributable to this source. However, for one of these sets of risk models this attributable fraction is materially dependent on how the radiation-induced risk is assumed to be transferred between the Japanese atomic bomb survivors and Western children. Over a range of annual doses representing the range (0.5-2.5 mSv/year) experienced by most populations, the attributable proportion for the preferred risk-transfer model varies between 8 and 30%, with small deviations from a linear relationship that are largely due to the saturation of the model, although again this range of attributable fractions depends on the assumed transfer of risk between populations.
Introduction
Leukaemia was the first type of cancer found to be in excess among the Japanese survivors of the atomic bombings of Hiroshima and Nagasaki in 1945. 1 Studies of other moderately or highly exposed groups have confirmed that leukaemia is particularly sensitive to induction by ionizing radiation; those exposed at young ages are especially at risk. 2, 3 Exposure to ionizing radiation at moderate or high levels, such as during the atomic bombings of Japan or as a result of radiotherapy, remains one of the very few established causes of leukaemia. [4] [5] [6] Statistical models ('risk models') have been developed to describe how the risk of radiation-induced leukaemia is expressed, on the basis of the findings of epidemiological studies of irradiated groups, mainly the Japanese atomic bomb survivors. 2, 3 These empirical risk models take into account the radiation dose to the target tissue (the red bone marrow (RBM)), the shape of the dose-response relationship (which has been found to be sub-linear, that is curving upwards) and various risk modifying factors, such as sex, age at exposure and time since exposure. These models reflect the large proportional increase in risk that has been observed among those exposed at a young age.
Exposure to low-level natural background ionizing radiation is ubiquitous, leading to a steadily accumulating dose received by the RBM from cosmic ray and terrestrial external sources of penetrating radiation, as well as from radionuclides taken into the body through inhalation and ingestion of various naturally occurring radioactive materials. 2, 3, 7, 8 Standard risk models, based on observations at higher doses, predict that this RBM dose from natural background radiation will induce some cases of leukaemia, especially among children, and the aim of this paper is to determine the level of this risk and the proportion of childhood leukaemia in Great Britain that may result from this largely unavoidable exposure. We then investigate the potential implications of this analysis, including whether the excess risk may be detected and quantified by direct epidemiological study. Finally, we examine the question of whether the risk can be approximated by a simple linear model over the range of doses that may be expected from natural background radiation. We employ for this purpose two sets of risk models for radiationinduced leukaemia that have been developed recently, in the Seventh Report of the US Committee on the Biological Effects of Ionizing Radiations (BEIR), 2 and in the 2006 Report of the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). 3 
Materials and methods

Red bone marrow doses
Simmonds et al. 9 estimated, by year of age, the RBM doses received from natural background radiation by a typical child living during the second half of the twentieth century in the village of Seascale on the coast of North-West England. The annual RBM dose received by a 10-year-old child was estimated to be about 1200 mSv, of which around 45% was from radionuclides in food and drink, about 45% from cosmic ray and terrestrial external sources of g-rays and approximately 10% from inhalation of radioisotopes of radon ( 222 Rn and 220 Rn) and their radioactive decay products. Note that radon and its progeny give most of their dose to the respiratory tract and make a much smaller contribution to the RBM dose than to the lung or effective doses. These dose estimates were for a specific part of the United Kingdom, but they do not differ substantially from those for a typical child resident in Great Britain. [7] [8] [9] More details of the age-specific RBM dose estimates are given in Supplementary Material A (Supplementary Table A1 ): the RBM absorbed doses (in gray, Gy) are separated into the high linearenergy-transfer (LET) component, consisting predominantly of the absorbed dose received from internally deposited radionuclides emitting short-range densely ionizing a-particles, and the low LET component, consisting of the absorbed dose received from sparsely ionizing g-rays and b-particles emitted from external or internal sources. To appropriately combine these two components of the absorbed dose, a radiation weighting factor (w R ) of 20 is applied to multiply the high LET absorbed dose to account for the greater degree of relevant biological damage produced by a-particles (the w R for low LET radiations is 1), and the resulting equivalent dose (in sievert, Sv) to the RBM is predicted by conventional risk models to be proportional to the overall risk of leukaemia arising from exposure to natural background ionizing radiation. 10 Childhood leukaemia incidence data Figure A1) . The National Registry of Childhood Tumours is a high-quality registry that, in recent years, provides effectively complete coverage of cases of childhood leukaemia occurring in Great Britain.
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Risk models
Radiation-induced leukaemia risk models have recently been published in the Seventh Report of the US BEIR Committee 2 and in the 2006 UNSCEAR Report. 3 These models, both based on the most recent mortality data for leukaemia in the Japanese atomic bomb survivors, 12 describe the expression over time of either the excess relative risk (ERR, the proportional increase in the leukaemia risk) or the excess absolute risk (EAR, the additional leukaemia risk), which, with sufficient sophistication of modelling, are equally satisfactory ways of describing the evolution of the radiation-induced risk of leukaemia in the atomic bomb survivors; the importance of the choice of ERR or EAR models to define the radiation-induced risk comes in their application to populations other than that from which the models are derived (see below). Both committees use the current leukaemia mortality data as the basis for their models, covering the period 1950-2000, from the Life Span Study of the Japanese atomic bomb survivors. 12 The models are based on mortality data for all types of leukaemia, as leukaemia incidence data using the latest (DS02) dosimetry system are not yet available and the most recent findings based on incidence data have 13 years fewer follow-up than those using mortality data. 12, 13 There is little evidence of chronic lymphocytic leukaemia being sensitive to induction by radiation, but this type of leukaemia is rare in Japan and does not occur in childhood. 2, 3 As most of the radiation-induced leukaemia risk among the bomb survivors was manifested at a time when leukaemia was almost invariably fatal, leukaemia mortality in the survivors is effectively equivalent to leukaemia incidence. 2, 3 A minimum latent period for leukaemia of 2 years and a dose-response that contains both linear and quadratic dose terms (a linear-quadratic doseresponse model) are adopted by both BEIR VII and UNSCEAR reports. As well as being dependent on the RBM dose, the models describe the radiation-induced risk in terms of certain risk-modifying factors: sex, age at exposure, time since exposure and attained age (although only two of these last three factors are independent). Details of the risk models are given in Supplementary Material B.
The BEIR VII and UNSCEAR leukaemia risk models only apply to radiation doses received after birth and not to doses received in utero. To accommodate the risk arising from the dose received in utero from natural background radiation, this intrauterine dose is assumed to generate an excess risk throughout childhood that is estimated by backwards extrapolation of the risk models (see Supplementary Material B), which should provide a reasonable approximation, as there is evidence that medical diagnostic X-ray exposure in utero induces a leukaemia risk that is compatible with that produced by the same level of exposure in early childhood 14 (although the interpretation of this evidence remains controversial 15 ). Having derived leukaemia ERR and EAR models from the Japanese bomb survivor data, the question then arises as to their applicability to other populations, such as British children. (In what follows we will refer to them as the 'transfer models'.) Transfer of the relative risk assumes that radiation interacts multiplicatively with background risk factors, whereas transfer of the absolute risk assumes that radiation acts additively with these factors. The BEIR VII Committee presented radiationinduced cancer risks for the US population and for leukaemia adopted as an estimate of the excess risk a weighted average of the results obtained from applications of the ERR and EAR models (requiring input of the baseline US leukaemia incidence rates), reflecting differences in the baseline risk distributions for leukaemia among the bomb survivors and in the US population and how radiation interacts with background risk factors. 2 The BEIR VII Committee considered that, from the available evidence on the transfer of leukaemia risk between populations, a 70% weight should be applied to the ERR model and a 30% weight to the EAR model to obtain the excess risk appropriate for US children, and these would seem to be appropriate weightings for British children when using the BEIR VII models. UNSCEAR did not make any specific recommendation on how the risk models that had been obtained from the Japanese atomic bomb survivor data should be transferred to other populations. However, the International Commission on Radiological Protection (ICRP) 10 has adopted a leukaemia EAR model based on earlier incidence data from the Japanese bomb survivors, 13 with the excess risk proportional to an exponential function of time since exposure, that is similar to the EAR model derived by UNSCEAR, in which the excess risk was proportional to a power of time since exposure (see Supplementary Material B). ICRP judged that only the leukaemia EAR should be transferred between populations so that, according to the Commission, only the EAR model should be used to determine the excess risk among British children. Given the uncertainty surrounding the transfer of leukaemia risk between populations, we present results assuming a pure ERR transfer model and a pure EAR transfer model, and also those obtained by using the ERR/EAR weighting scheme proposed by the BEIR VII Committee.
The numbers of cases and the proportions of childhood leukaemia in Great Britain during 1991-2000 that are attributable to natural background radiation are calculated by using the BEIR VII and UNSCEAR leukaemia risk models and ERR and EAR transfer models with the age-specific RBM equivalent doses shown in Supplementary Table A1. The observed incidence rates shown in Supplementary Figure A1 are, of course, a combination of the rates due to natural background radiation and the rates due to all other causes, and the computations take this into account; details of the adjustments are given in Supplementary Material B. The main results are for the estimates of the RBM doses from natural radiation presented by Simmonds et al. 9 However, in a sensitivity analysis, selected results are also given for age-invariant annual RBM doses of 0.5, 1.0, 1.5, 2.0 and 2.5 mSv per year.
Results
The numbers of cases and the proportions of childhood leukaemia by year of age predicted to be attributable to exposure to natural background ionizing radiation in Great Britain during 1991-2000 by the BEIR VII and UNSCEAR leukaemia risk models are shown in Table 1a and b, respectively. The contribution of excess cases at age 1 year is a consequence of in utero exposure. It will be seen that, using the BEIR VII recommended 70% ERR/30% EAR transfer-model mixture, the overall predictions of the percentages of cases of leukaemia up to the fifteenth birthday from the BEIR VII and UNSCEAR risk models are broadly similar at B20%. With this mixed transfer model, the BEIR VII risk model predicts that the attributable fraction of leukaemia induced by natural radiation rises during the first 5 years of life and then remains broadly constant, whereas the UNSCEAR risk model predicts that the attributable fraction is greatest at 2 years of age and then decreases steadily with increasing attained age. Of note is the difference between the predictions of the BEIR VII and UNSCEAR ERR and EAR risk models: although there is little difference between the predictions of the BEIR VII ERR and EAR models, those of the UNSCEAR ERR and EAR models are substantially different. As a consequence, for the UNSCEAR models, but not for the BEIR VII models, attributable numbers and proportions are heavily dependent on the risk-transfer model, that is on the assumed nature of transfer of radiationinduced leukaemia risk from the Japanese atomic bomb survivor population to the population of British children. Under the assumption that the EAR only should be transferred between populations, the UNSCEAR risk model predicts that approximately 5% of cases are attributable to background radiation, substantially less than that given by the 70/30 weighted ERR/ EAR mixture of 23%. Childhood leukaemia caused by natural background radiation R Wakeford et al Table 2 shows the effects of age-invariant annual RBM doses of 0.5, 1.0, 1.5, 2.0 and 2.5 mSv per year under the UNSCEAR risk model. The table shows that, using the 70% ERR/30% EAR mixture, the attributable fraction of childhood leukaemia increases from B8% at an annual dose rate of 0.5 mSv/year to B30% at 2.5 mSv/year. Table 2 also shows the slight nonlinearity in the relation between attributable fraction and annual RBM dose, which is as one would expect: at higher dose rates each increment in dose produces a smaller increment in attributable fraction than that at lower dose rates. Table 2 also shows that neglecting the dose received in utero results in a reduction of about 20-25% in the attributable risk for the pure ERR and the 70% ERR/30% EAR mixture models, although a rather smaller reduction, of about 10%, for the pure EAR model is seen.
Discussion
Using the recently published risk models of BEIR VII 2 and UNSCEAR 3 together with estimates of the RBM doses received by children from natural background radiation, we have estimated that about 20% of the cases of childhood leukaemia in Great Britain are associated with this exposure. However, for the UNSCEAR models, this attributable fraction is materially dependent on the assumed nature of the transfer of risk between populations.
The uncertainty surrounding the transfer of risk between populations is emphasized by the radiation-induced leukaemia risk model developed in the Fifth Report of the BEIR Committee, 16 which is a pure ERR model derived from the earlier leukaemia mortality data for the Japanese atomic bomb survivors during 1950-1985. Using the BEIR V leukaemia risk model, 19 .7% of all male (511) and 18.9% of all female (374) cases of childhood leukaemia, diagnosed during 1991-2000 in Great Britain, are predicted to be attributable to natural background radiation, comparable to an earlier estimate that around one-fifth of British childhood leukaemia cases could be due to this source of radiation exposure. 17 The difference (at least when employing the UNSCEAR risk models) in the results obtained from using the ERR and EAR models, derived from the experience of the Japanese atomic bomb survivors in the 1950s to estimate the effects in British children in the 1990s, is the consequence of the materially lower background risk of leukaemia among the Japanese children. The baseline annual paediatric (0-14 years of age) leukaemia mortality rate for the Japanese atomic bomb survivors was 18 deaths per million person-years, 14 whereas in Great Britain during 1991-2000 the baseline incidence rate was 45 cases per million person-years, 11 a factor of 2 1 2 difference. The markedly lower childhood leukaemia mortality rates in Japan in the 1950s when compared with contemporary rates in Great Britain and the USA were noted in early reviews. 18, 19 Since the 1950s leukaemia incidence among Japanese children has grown appreciably, primarily because of the rise in the incidence of acute lymphoblastic leukaemia in young children, 20 so that the rate of incidence of childhood leukaemia in Japan is now comparable to that in Great Britain. 21 The question naturally arises as to what transfer of risk between the Japanese atomic bomb survivors and British children in the 1990s is appropriate under these circumstances. The BEIR V Committee and the ICRP take opposite views, selecting pure relative risk and pure absolute risk transfers, respectively, whereas the BEIR VII Committee chooses a 70/30 mixture of risks. Unfortunately, the justification for the choice of leukaemia risk transfer that has been selected by these bodies is minimal, making difficult a judgement on what model weighting to apply to British children.
To resolve this question of the most appropriate transfer of risk, estimates of the ERR and EAR coefficients from the Japanese atomic bomb survivor data should ideally be compared with equivalent estimates from Great Britain during the late twentieth century to determine whether a relative or an absolute risk transfer, or some mixture, gives the most accurate result. Unfortunately, whereas studies of radiation-induced leukaemia among Western children exposed to radiation for therapeutic purposes show clear evidence of an excess risk, the dosimetry in these studies is generally insufficient to provide a reliable estimate of the risk per unit RBM dose received. Wakeford and Little 14 found that the leukaemia ERR coefficients derived from British children exposed to diagnostic radiography in utero in the mid-1950s and from the Japanese survivors irradiated in the first few years of postnatal life were more compatible than the EAR coefficients, but the uncertainties are substantial. There are 23 The leukaemia mortality EAR in the Stockholm skin haemangioma study 24 is 0.58 Â 10
À4
/PY/Gy (95% CI: À0.28, 1.72), whereas the ERR is 2.12/Gy (95% CI: À0.70, 10.18). 23 The leukaemia mortality EAR in the Netherlands nasopharyngeal radium irradiated cohort 25 is 0.50 Â 10 À4 /PY/Gy (95% CI: À0.54, 1.64), whereas the ERR is 2.3/Gy (95% CI: À1.0, 15.5). 23 Comparable figures for the Japanese atomic bomb survivors exposed as children can be estimated to be for the EAR: 2.13 Â 10
/PY/Sv (95% CI: 1.37, 3.06), and for the ERR: 9.48/ Sv (95% CI: 5.03, 17.71). 23 As noted by Little, 23 there is statistically significant (P ¼ 0.046) heterogeneity between these EAR values, but none between the ERR estimates (P ¼ 0.335). These comparisons (which consider leukaemia at all ages after exposure during childhood) suggest that a relative risk transfer may be more appropriate than an absolute risk transfer between the Japanese atomic bomb survivors and these Western childhood populations.
The BEIR VII and UNSCEAR risk models apply only to exposures received after birth, but these models have had to be applied to the dose from natural background radiation received in utero. Comparison of the childhood leukaemia ERR coefficient for fetal exposure to diagnostic X-rays with that for exposure of the Japanese atomic bomb survivors in early postnatal life suggests that this approximation is not unreasonable, 14 and that alternative risk estimates for exposure in utero, for example that derived by Wakeford and Little 14 directly from the Oxford Survey of Childhood Cancers, are not likely to produce results that are substantially different. The findings of this paper, however, are somewhat sensitive to whether one adopts this approximation or assumes that the in utero dose has no effect on the subsequent development of leukaemia in childhood, as neglecting the dose received in utero results in a 10-25% reduction in attributable risk (Table 2) .
In addition to the uncertainty associated with the transfer of risk between populations, there is material imprecision associated with the models themselves, reflecting the relative sparseness of the data on which they are based. Thus, estimates of the ERR coefficient for childhood leukaemia may have an imprecision as large as an order of magnitude, 2, 16 and systematic biases may also be present, such as the error that would arise from an inappropriate assumption regarding the extrapolation of the dose-response from moderate doses to low doses. Moreover, systematic follow-up of the Japanese atomic bomb survivors did not commence until October 1950, although there is strong evidence for an excess of leukaemia deaths among the survivors before this date, 1 which adds further uncertainty to the risk models. The uncertainty present in the models is illustrated by the differences in the predictions of the BEIR VII and UNSCEAR leukaemia risk models, which are based on the same set of leukaemia mortality data for the Japanese atomic bomb survivors, 12 and these differences are likely to be largely a reflection of the assumptions made about the nature of the risk in the years before systematic follow-up of the survivors commenced.
Even comparing the same component parts of each model (ERR, EAR), there are substantial differences between the BEIR VII and UNSCEAR models. These are most pronounced for the EAR models, as shown by Table 1a and b. For example, the male EAR at age 5 years predicted by the UNSCEAR EAR model following exposure to 1 mSv at age 0 year is 2.8 Â 10 À7 , whereas for the BEIR VII model the analogous calculation yields 3 it is generally considered unwise to have interaction terms in a model without both associated main effect terms. These sources of uncertainty need to be borne in mind when assessing the predictions of the risk models.
An additional source of inaccuracy lies in the estimates of the age-specific RBM doses from natural background radiation. The estimates of Simmonds et al., 9 have been used in this paper, but the RBM doses in Great Britain are currently undergoing reevaluation, an exercise that will also assess the geographical variation in the doses. Two factors affect RBM doses: the overall magnitude of each component (e.g. g-ray dose-rate or intakes of various radionuclides) and the contribution that each makes to RBM dose. Low LET radiation is reasonably penetrating and gives similar doses to adjacent tissues. However, high LET aparticles have very short ranges and the calculated doses depend critically on assumptions made about the relationship between the distributions of radionuclides in the tissue and the cells sensitive to the induction of leukaemia.
Could this predicted risk of childhood leukaemia arising from exposure to natural background radiation be detected and quantified by direct epidemiological study? Given the comparatively small number of attributable cases under the assumption of an absolute risk transfer, it seems most unlikely that the predicted excess risk could be identified under these circumstances, but if the risk transfer is predominantly relative then the inference that around one-fifth of childhood leukaemias may be caused by exposure to natural background radiation raises the distinct possibility of detection through epidemiological study. However, as pointed out by Greaves, 5 epidemiological studies conducted to date have not provided persuasive evidence for any influence of background radiation on childhood leukaemia risk. Geographical correlation studies have been conducted of nearly 7000 cases of childhood leukaemia and non-Hodgkin's lymphoma diagnosed during 1969-1983 in 459 county districts of Great Britain. [26] [27] [28] Muirhead et al., 26, 27 in a study of both leukaemia and non-Hodgkin's lymphoma, found ambiguous results suggestive of confounding by socio-economic factors. Richardson et al., 28 in a study restricted to leukaemia, found no association with either gamma radiation or radon and its radioactive decay products once non-random background geographical variations in incidence had been taken into account. Similarly, the UK Childhood Cancer Study, a nationwide case-control study of childhood cancer in Great Britain, found no association between childhood leukaemia and either gamma radiation 29 or radon. 30 A recent case-control study in Denmark 31 found an association between domestic radon exposure and childhood acute lymphoblastic leukaemia, and the authors concluded that 9% of childhood acute lymphoblastic leukaemia cases in Denmark are attributable to exposure to radon, although the lower 95% confidence limit for this attributable fraction is 1% of cases. An ecological correlation study in France also showed a significant positive association of childhood leukaemia with residential radon exposure, but not with background g-radiation. 32 However, in neither the Danish nor the French study were individual dose measurements used. Ecological studies have been conducted in various high background areas, in particular those in China, 33, 34 India 34,35 and Iran. 36 Of these, only the Chinese study is well developed, and as yet there are no indications of an excess risk of childhood leukaemia. 33, 34 The radon component of the overall RBM doses estimated by Simmonds et al., 9 is rather less than 10%, suggesting that, under the 70/30 ERR/EAR model mixture, only about 2% of childhood leukaemia cases in Great Britain are due to exposure to radon and its radioactive progeny. As noted in Supplementary Material A, the doses from radon and other internally deposited radionuclides are those used by Simmonds et al., 9 which are based on ICRP models that were in use at the time. More up-to-date ICRP models are now available, in particular for the embryo and fetus, [37] [38] [39] but as this component of dose is in any case fairly modest, it is unlikely that use of the current dosimetric models would materially change the risk estimates we derive. More recent calculations of the doses from natural radiation would assign a broadly similar fraction to radon and its decay products, 8, 40 but, as noted above, there are considerable uncertainties in the modelling that underlies these estimates, including the RBM dose arising from the inhalation of radon. Further, the average exposure to radon in countries such as Denmark or France 31, 32 is much greater than in Great Britain. Nevertheless, on our present understanding it seems unlikely that exposure to radon is responsible for a substantial proportion of childhood leukaemia, although in certain parts of the UK, or in other countries (for example, Denmark, France 31, 32 ) where radon levels are much higher than the UK national average, the component of leukaemia risk attributable to this exposure will be greater.
The lack of convincing epidemiological evidence for natural background radiation causing a material fraction of childhood leukaemia incidence could be due to a number of reasons. In reality, the number of background radiation-induced cases could actually be too small to detect -if, for example, the risk transfer is predominantly absolute or if the dose-response models assumed by standard risk models overestimate the risk of leukaemia at low doses. On the other hand, the statistical power of many of the studies that have been carried out may be insufficient to identify a risk from background radiation that is, nonetheless, reasonably large. Too few cases included in a study is an obvious cause of low statistical power, but one aspect that could well be important is the geographical or inter-individual variation in the RBM dose. Possible correlations between radiation exposure and other factors that affect leukaemia, particularly if these were acting within the units over which measurements were averaged, could also act to disguise any real association of leukaemia and natural background radiation, and would be particularly difficult to detect. If the variation in the RBM dose between areas or individuals is small, then it will be difficult to discern any excess risk arising from background radiation. Indeed, the proportion of cases caused by background radiation could be substantial and remain undetected by a large study because there is insufficient variation in the risk to permit its manifestation.
The main reason why it has been possible to identify the risk of lung cancer due to the inhalation of radon and its decay products against the dominant background risk of lung cancer due to tobacco smoke is that radon dominates the radiation dose to the lung, and radon concentrations vary geographically to a marked extent. In principle, this marked geographical variation could be the explanation for the reported associations between radon and childhood leukaemia, though, as noted above, estimates of the RBM dose from exposure to radon suggest that a causal explanation is unlikely.
Epidemiological studies have normally been carried out using estimates of two components of natural background radiation dose: that from terrestrial sources of g-rays together with the directly ionizing component of cosmic rays, and that from radon and its decay products; the former greatly outweighs the latter in its contribution to RBM dose. Data presented by Kendall et al. 8 indicate that the distributions of dose-rate from terrestrial g-rays and from cosmic rays are approximately normal, with a mean of about 95 nGy/h and a standard deviation about 25 nGy/h. Comparable figures have been derived by the UK Childhood Cancer Study. 29 The variation in the RBM dose in Great Britain is currently being assessed in more detail, which will allow a closer examination of the statistical power of epidemiological studies of childhood leukaemia and the impact upon the conclusions for the influence of natural background radiation on childhood leukaemia incidence.
In radiation protection, it is normal to assume that the deleterious effects of radiation can, at low doses and/or low dose-rates, be approximated by a linear no-threshold model. Table 2 shows the predicted numbers of childhood leukaemias induced by constant annual RBM doses of 0.5-2.5 mSv. This range of doses covers those normally incurred from natural background in the UK and in many other countries. 3 As shown, there is an approximately linear increase in probability with dose rate, mirroring the dominant linear term in the dose response at low doses. Because a significant fraction of the total number of childhood leukaemias is predicted to be attributable to background radiation, the underlying rates must be adjusted to take account of this effect, as has been done here. The slight sub-linearity that is observed is largely due to saturation in the attributable fraction: one cannot induce leukaemia twice, and the proportion must always be less than 100%.
